Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still ...
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much ...
A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback